Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 3
2005 1
2006 2
2008 2
2009 4
2010 5
2011 2
2012 3
2013 6
2014 2
2015 4
2016 1
2017 8
2018 5
2019 6
2020 5
2021 1
2022 6
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Results by year

Filters applied: . Clear all
Page 1
Targeting metabolic adaptive responses induced by glucose starvation inhibits cell proliferation and enhances cell death in osimertinib-resistant non-small cell lung cancer (NSCLC) cell lines.
Eltayeb K, Alfieri R, Fumarola C, Bonelli M, Galetti M, Cavazzoni A, Digiacomo G, Galvani F, Vacondio F, Lodola A, Mor M, Minari R, Tiseo M, La Monica S, Giorgio Petronini P. Eltayeb K, et al. Among authors: cavazzoni a. Biochem Pharmacol. 2024 Mar 24:116161. doi: 10.1016/j.bcp.2024.116161. Online ahead of print. Biochem Pharmacol. 2024. PMID: 38522556 Free article.
Targeting glucosylceramide synthase induces antiproliferative and proapoptotic effects in osimertinib-resistant NSCLC cell models.
La Monica S, Vacondio F, Eltayeb K, Lodola A, Volta F, Viglioli M, Ferlenghi F, Galvani F, Galetti M, Bonelli M, Fumarola C, Cavazzoni A, Flammini L, Verzè M, Minari R, Petronini PG, Tiseo M, Mor M, Alfieri R. La Monica S, et al. Among authors: cavazzoni a. Sci Rep. 2024 Mar 18;14(1):6491. doi: 10.1038/s41598-024-57028-8. Sci Rep. 2024. PMID: 38499619 Free PMC article.
State of the art and perspectives in pediatric hepatocellular carcinoma.
Digiacomo G, Serra RP, Turrini E, Tiri A, Cavazzoni A, Alfieri R, Bertolini P. Digiacomo G, et al. Among authors: cavazzoni a. Biochem Pharmacol. 2023 Jan;207:115373. doi: 10.1016/j.bcp.2022.115373. Epub 2022 Dec 10. Biochem Pharmacol. 2023. PMID: 36513143 Review.
CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cells.
Digiacomo G, Fumarola C, La Monica S, Bonelli M, Cavazzoni A, Galetti M, Terenziani R, Eltayeb K, Volta F, Zoppi S, Bertolini P, Missale G, Alfieri R, Petronini PG. Digiacomo G, et al. Among authors: cavazzoni a. Front Oncol. 2022 Jul 22;12:942341. doi: 10.3389/fonc.2022.942341. eCollection 2022. Front Oncol. 2022. PMID: 35936714 Free PMC article.
67 results